Evidence map›Paper›PMID 23660079›Full record

ReviewDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver2013

Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders.

Hamed Laroui, Poonam Rakhya, Bo Xiao, Emilie Viennois, Didier Merlin

Abstract readReview
In one paragraph

Review in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Current and emerging approaches to manage chronic inflammatory gut disorders.Frontiers in cellular and infection microbiology · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Nanotools for Sepsis Diagnosis and Treatment.Advanced healthcare materials · 2021
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Nanomedicines in gastroenterology and hepatology.Nature reviews. Gastroenterology & hepatology · 2015
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hamed LarouiDepartment of Biology, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA, USA. Electronic address: hlaroui@gsu.edu.
Poonam Rakhya
Bo Xiao
Emilie Viennois
Didier Merlin

Funding

ROLE OF CD98 IN INTESTINAL PERMEABILITYR01DK071594 · NIDDK · GEORGIA STATE UNIVERSITY · PI MERLIN, DIDIER · 2006 to 2017
$3.3M
Neutrophil-Epithelial Interaction Mediated by AdenosineR01DK064711 · NIDDK · GEORGIA STATE UNIVERSITY · PI MERLIN, DIDIER · 2004 to 2013
$3.1M
Role of CD98 Glycoprotein in Intestinal InflammationK01DK097192 · NIDDK · GEORGIA STATE UNIVERSITY · PI LAROUI, HAMED · 2012 to 2016
$500k
NIDDK NIH HHS K01 DK097192NIDDK NIH HHS K01-DK097192NIDDK NIH HHS R01-DK-064711NIDDK NIH HHS R01 DK071594NIDDK NIH HHS R01-DK 071594
6 · The paper itself

Abstract

This review describes the state of the art in nanoparticle and nanodevice applications for medical diagnosis and disease treatment. Nanodevices, such as cantilevers, have been integrated into high-sensitivity disease marker diagnostic detectors and devices, are stable over long periods of time, and display reliable performance properties. Nanotechnology strategies have been applied to therapeutic purposes as well. For example, nanoparticle-based delivery systems have been developed to protect drugs from degradation, thereby reducing the required dose and dose frequency, improving patient comfort and convenience during treatment, and reducing treatment expenses. The main objectives for integrating nanotechnologies into diagnostic and therapeutic applications in the context of intestinal diseases are reviewed.

Indexed as

NanomedicineColorectal NeoplasmsDendrimersGastrointestinal DiseasesHumansInflammatory Bowel DiseasesLiposomesNanoshellsNanostructuresNanowiresQuantum DotsDendrimersLiposomesDiagnosticsGastroenterologyNanotechnologyTherapeutics

Identifiers

PMID23660079
PMCPMC3970315

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.